Suppression of CD4+ T-Cells in the Spleen of Mice Infected with Toxoplasma gondii KI-1 Tachyzoites by Kim, Won-Hee et al.
Toxoplasma gondii is a protozoan parasite that is controlled by
the host immune system [1]. Although infection with T. gondii
is generally asymptomatic in healthy adults, it may result in
abortion, death, and severe neurologic sequelae in neonates,
and life-threating lesions in AIDS patients [2,3]. T. gondii infects
a variety of vertebrate species, including humans, and domestic
and wild cats serve as the definitive host for this parasite [3].
Transmission of T. gondii can occur by ingestion of oocysts in
feline feces, tachyzoites in blood or body fluid of infected ani-
mals, and cysts (bradyzoites) in chronically infected tissues of
pigs, or by vertical transmission from mothers to newborns [2]. 
Toxoplasmosis is a common protozoan infection in the Uni-
ted States with seroprevalence of about 15.8% among the age-
adjusted population (12-49 years of age) and 14.9% among
women [4]. In the Republic of Korea, the seroprevalence was
reported to be around 2-7% [5], and clinical toxoplasmosis
cases have been reported [6]. Recently, tachyzoites of T. gondii
successfully isolated from blood of an ocular patient have been
maintained in the laboratory and designated as KI-1 isolate [7].
Its characteristics, including the morphology, virulence, infec-
tivity, cell culture characteristics, and genetic properties, were
identical to those of RH strain, a well-known virulent strain origi-
nating from a child who suffered from encephalitis [7,8]. 
One of the most distinctive immunologic features of T. gondii
infection is strong and persistent cell-mediated immunity which
protects the host from the rapid tachyzoite growth and conse-
quent pathology [2,3]. The highly effective resistance is thought
to be mediated mainly by T-lymphocytes, in particular, CD4
+
(helper) T-cells and CD8
+ (cytotoxic) T-cells [9,10]. Resistance
is associated with highly polarized Th1-type cytokine expres-
sions; for example, IFN-g plays a major role in acquired immu-
nity to acute infection and in the control of parasite growth in
chronically infected hosts [11,12]. However, T. gondii subverts
the host immune system [13] and can induce host immuno-
suppression [3,14-16]. Host immunosuppression may cause
variable negative clinical effects in humans and mice, including
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Abstract: Toxoplasma gondii KI-1, a recent new isolate from Korea, shows similar pathogenicity and infectivity to mice
compared to the virulent RH strain. To understand characteristics of host immunity, including immune enhancement or
suppression, we investigated proliferative responses and phenotypes of spleen cells. In addition, kinetics of IFN-g, a Th1
cytokine, was examined in BALB/c mice up to day 6 post-infection (PI). Intraperitoneal injection of mice with 10
3 KI-1 tachy-
zoites induced significant decreases (P < 0.05) in proliferative responses of spleen cells. This occurred at days 2-6 PI even
when concanavalin A (con A) was added and when stimulated with KI-1 antigen, suggesting suppression of the immuni-
ty. CD4
+ T-cells decreased markedly at day 2 PI (P < 0.05), whereas CD8
+ T-cells, NK cells, and macrophages did not
show significant changes, except a slight, but significant, increase of CD8
+ T-cells at day 6 PI. The capacity of splenocytes
to produce IFN-g by con A stimulation dropped significantly at days 2-6 PI. These results demonstrate that intraperitoneal
injection of KI-1 tachyzoites can induce immunosuppression during the early stage of infection, as revealed by the decrease
of CD4
+ T-cells and IFN-g.
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ISSN (Online)  1738-0006prolonged pregnancy, retarded embryonic growth, and increased
prevalence of chromosomal anomalies [17]. Immunologic char-
acteristics of KI-1, including immunosuppression of the host,
have never been studied. Therefore, the present study focused
on understanding the immune responses of BALB/c mice, in-
cluding immunosuppression, after intraperitoneal infection
with KI-1 tachyzoites.
Female BALB/c mice, 5-8 week-old, were purchased from
SPF animal center (Koatech Comp., Gyeonggi-do, Republic of
Korea). KI-1 tachyzoites were maintained every 5-6 days by
intraperitoneal injection into BALB/c mice [13]. The peritoneal
exudate was harvested, washed with sterile PBS, and pelleted
by centrifugation for 10 min at 3,000 rpm [20]. Tachyzoites
were purified using 40% Percoll (Pharmacia Biotech, Uppsala,
Sweden) in PBS [20]. The purified tachyzoites were disrupted
by 5 cycles of freezing and thawing, and homogenated. The
homogenates were centrifuged at 12,000 rpm at 4℃ for 30
min and the supernatants were used as the KI-1 antigen after
filtration through a 0.45 mm membrane (Advantec MFS Inc.,
Pleasanton, California, USA). 
Five mice in each group were infected with 10
5 KI-1 tachy-
zoites by intraperitoneal injection. At days 0 (control), 2, 4,
and 6 post-infection (PI), the mice were sacrificed under ether
anesthesia. The spleens were removed aseptically and kept in
cold complete RPMI 1640 media (Gibco BRL, Grand Island,
New York, USA) containing 10% heat-inactivated FBS, 2 mM
L-glutamine, and 100 IU/ml of penicillin G, and 100 mg/ml of
streptomycin. Spleen tissues were prepared to single cell sus-
pension and RBC was lysed using a hypotonic buffer contain-
ing NH4Cl [20]. Finally, cells were resuspended in complete
RPMI 1640 media and viable cells were counted by trypan blue
exclusion test. Concanavalin A (con A) (Sigma-Aldrich, St. Louis,
Missouri, USA), at a final concentration of 5 mg/ml, was pre-
pared and stored at -70℃ A 40 ml (4 × 10
5 cells) of the spleen
cell suspension was used for cell proliferation assay and a 100
ml (1 × 10
6 cells) cell suspension was for fluorescence-activat-
ed cell sorter (FACS) staining. To avoid non-specific binding of
fluorescein-conjugated antibody, Fc blocker (anti-CD16/32
(Fcg III/II receptor) (eBioscience, Boston, Massachusetts, USA)
was used prior to labeling of anti-mouse CD3, CD4, CD8, DX5,
or F4/80 antibodies. Cells were stained with fluorescein isoth-
iocyanate (FITC)-conjugated anti-CD3 (eBioscience), phyco-
erythrin (PE)-conjugated anti-CD4, cyanin 5-phycoerythrin
(Cy5-PE)-conjugated anti-CD8, PE-conjugated anti-DX5, and
Cy5-PE-conjugated anti-F4/80 (eBioscience). Phenotypic analy-
sis of CD4
+ or CD8
+ T-cells, NK cells, and macrophages was per-
formed by FACScan flow cytometer (Becton-Dickinson, Ruther-
ford, New Jersey, USA). Gates were set to exclude non-viable
cells and adjusted to detect specifically stained cells [19]. 
Cell proliferation assays were carried out in triplicate in 96-
well flat-bottomed plates (NUNC Int., Rochester, New York,
USA) in a 0.2 ml volume under the following conditions: 4 ×
10
5 cells per well in 0.2 ml of culture media alone or in media
containing 100 mg/ml KI-1 lysate antigen (TLA,) or 5 mg/ml con
A. Plates were incubated for 72 hr in 5% CO2 at 37℃ and viable
cells were converted to a colored product using XTT solution
[2,3-Bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide] (Roche Diagnostics GmbH, Mannheim, Ger-
many). A mixture of 1 ml phenazine methosulphate (PMS; elec-
tron-coupling reagent) and 50 ml of the XTT labeling reagent
was added to each well and incubated at 37℃ during the last 4
hr of culture. Absorbance of the colored culture media was read
at 450 nm with a reference wavelength of 650 nm (ELx808)
(BioTek Instruments, Winooski, Vermont, USA). IFN-g levels
were measured using sandwich ELISA after the spleen cells were
cultured with con A or TLA. The standard concentrations of
cytokines were measured serially at 1/2-1/32 dilutions on mu-
rine recombinant IFN-g (eBioscience). Plates were incubated
for 2 hr at room temperature, and after 5 washes, biotinylated-
anti-mouse IFN-g (eBioscience) was added in each well and the
plates were further incubated for 1 hr. Avidin-HRP (at 1/250)
(eBioscience) was added to each well, and the plates were incu-
bated for 30 min. Absorbance was measured at 450 nm using
the Precision Microplate Reader (Molecular Devices, Sunnyvale,
California, USA). Data are shown as mean ± SD and statisti-
cally analyzed by the Student’s t-test. Values of P < 0.05 were
considered statistically significant.
The proliferative capacity of the splenocytes of uninfected
mice (day 0 PI) increased after the addition of con A (Fig. 1).
However, the proliferative capacity of the splenocytes of KI-1
infected mice decreased significantly at day 2 (P = 0.000), day
4 (P = 0.000), and day 6 PI (P = 0.0011) after the addition of
con A compared with uninfected controls, suggesting immuno-
suppression (Fig. 1). Similarly, the splenocytes of the infected
mice had significantly lowered responses to stimulation with
KI-1 antigen at day 2 (P = 0.0008), day 4 (P = 0.000), and day
6 PI (P = 0.0388), compared to the uninfected controls which
also suggests suppression of immune responses (Fig. 1).
CD4
+ T-cells were decreased from 25.4% at day 0 PI to 19.1%
at day 2 PI and slowly recovered to the level of uninfected mice
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+ T-cells increased slightly
but steadily during the whole infection period, though statisti-
cal significance was shown only at day 6 PI (Fig. 2). Macropha-
ges and NK cells showed only slight changes during the infec-
tion period, though at days 2, 4 (NK cells only), and 6 PI their
levels were significantly lower than those of uninfected controls
(P < 0.05) (Fig. 2). 
Con A stimulation of the splenocytes induced production of
over 600 pg/ml of IFN-g in uninfected mice (Fig. 3). However,
the splenocytes of infected mice showed significantly (P < 0.05)
depressed production of IFN-gdespite con A stimulation at days
2-6 PI compared with the controls (Fig. 3). On the other hand,
the splenocytes of infected mice showed no significant respons-
es to KI-1 antigen stimulation at days 2-6 PI (Fig. 3).
The results of the present study have demonstrated that intra-
peritoneal infection with T. gondii KI-1 tachyzoites can induce
severe immunosuppression of BALB/c mice. The splenocytes of
KI-1 infected mice did not respond to in vitro stimulation with
con A or KI-1 antigen up to day 6 PI. In addition, the propor-
tion of CD4
+ T-cells among the splenocytes and IFN-g produc-
tion by the splenocytes were both significantly decreased in in-
fected mice compared to the controls.
During the early stages of Toxoplasma infection, macrophages
and NK cells become activated and produce cytokines, includ-
ing IFN-g, which induce cell-mediated immune responses [3].
CD4
+ T-cells are essential for inflammation responses against T.
gondii infection and have an important role in the maintenance
of CD8
+ T-cell immunity against this protozoan parasite [21].
In our study, the proliferative capacity of the splenocytes by con
A or Toxoplasma antigen stimulation was markedly suppressed
in KI-1 infected mice at days 2-6 PI. In addition, the ratios of
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Fig. 1. Proliferative responses of splenocytes isolated from unin-
fected (day 0 PI) and T. gondii KI-1 tachyzoite-infected (days 2, 4,
and 6 PI) BALB/c mice. Proliferation was assayed by XTT method
72 hr after stimulation with 5 mg/ml con A (spleen cells + con A) or
100 mg/ml KI-1 lysate antigen (spleen cells + KI-1 antigen) and com-
pared with the unstimulated group (spleen cells only). 
*Significantly lower (P < 0.05) than uninfected controls.
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Fig. 2. Proportions of CD4
+ T-cells, CD8
+ T-cells, NK cells, and ma-
crophages among the phenotypes of splenocytes in uninfected
(day 0 PI) and T. gondii KI-1 tachyzoite-infected (days 2, 4, and 6
PI) BALB/c mice. Cells were stained with phycoerythrin (PE)-con-
jugated anti-CD4, cyanin 5-phycoerythrin (Cy5-PE)-conjugated
anti-CD8, PE-conjugated anti-DX5, and Cy5-PE-conjugated anti-
F4/80, respectively. Phenotypic analysis was performed by a FAC-
Scan flow cytometer. *Significantly lower (P < 0.05) than in unin-
fected controls (day 0 PI).
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Fig. 3. IFN-g production by splenocytes isolated from uninfected
(day 0 PI) and T. gondii KI-1 tachyzoite-infected (days 2, 4, and 6
PI) BALB/c mice, as measured by the sandwich ELISA. The levels
were measured 72 hrs after stimulation with 5 mg/ml con A (spleen
cells + con A) or 100 mg/ml KI-1 lysate antigen (spleen cells + KI-1
antigen) and compared with the unstimulated group (spleen cells
only). *Significantly lower (P < 0.05) than in uninfected controls (day
0 PI).CD4
+ T-cells, macrophages, and NK cells among the splenocytes
of KI-1 infected mice were significantly down-regulated up to
day 6 PI. However, CD8
+ T-cells steadily increased during the
infection period, suggesting that these cells may be important
in response to T. gondii infection [21]. CD8
+ T-cells can lyse tachy-
zoites released from cells and are directly cytotoxic to infected
host cells [21]. Our data suggested that the increased CD8
+ T-
cells may be important as a protective response against KI-1 in-
fection. The importance of CD8
+ T-cells in protection against T.
gondii was also reported in mice vaccinated with dendritic cells
[22].
The host immunity against T. gondii infection is known to be
predominantly a cell-mediated type and characterized by high-
ly polarized Th1 responses [3]. Both CD4
+ and CD8
+ T-cells are
known for their ability to produce high levels of IFN-gin respon-
se to the parasite [3], and IFN-g has a crucial role in resistance
to T. gondii at both the acute and chronic stages of infection
[11,12,23]. However, our data showed only limited produc-
tion of IFN-g together with suppressed CD4
+ T-cell levels in the
spleen of KI-1 infected mice, which may be related to the fail-
ure of these mice to survive beyond day 7 PI [7]. CD4
+ T-cell
suppression was also observed in T. gondii-infected mouse reti-
nal cells, and the suppression was mediated by the cell surface
protein, programmed death ligand 1 (PD-L1) [24].
Taken together, our study demonstrated that infection of
BALB/c mice with T. gondii KI-1 tachyzoites resulted in marked
suppression of the host immune responses, in particular in CD4
+
T-cells and IFN-g levels, during the early stages of infection. We
suggest that this markedly suppressed immunity in KI-1 infected
mice may be responsible for their early death before day 7 PI. 
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